
Monte Rosa Therapeutics is seeking an energetic and highly motivated B-Cell Biologist for a 6 month contract, located in Boston to support the development and characterization of novel molecular glue degraders for the treatment of autoimmune and inflammatory diseases. As part of the Discovery Immunology team, this role will broadly support multiple immunology and inflammation (I&I) projects/programs, both in vitro and ex vivo, from early discovery through lead optimization.
The ideal candidate is an immunologist with a strong technical background in B cell immunology, particularly with primary human and mouse cells/tissues, and a demonstrated ability to move projects/programs forward through collaborative teamwork.

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.